流感疫苗接种与肩痛就诊增加无关
本研究基于2009至2018年一所大学健康服务机构的24,206次流感疫苗接种记录,比较接种前后3个月内因肩痛就诊的比例。结果显示接种前为1.1%(52/4801),接种后为1%(40/3977),风险比1.1(95%CI 0.8-1.5;p=0.72),无显著差异。结论认为因肩痛就诊在接种后并未增加,但无法排除罕见的疫苗接种特异性肩部病变。
要点
- 流感疫苗接种前后3个月内肩痛就诊比例无显著差异(1.1% vs 1%,p=0.72)。
- 肩痛就诊最常见原因为非创伤性肩痛,占79%(134/170)。
- 基于时间顺序假定接种后肩痛为疫苗伤害可能带来误诊和不恰当处理的风险。
核心结论
- 流感疫苗接种后3个月内因肩痛就诊的比例与接种前无差异,不支持接种后肩痛普遍增加。
- 研究无法排除与疫苗接种相关的罕见特异性肩部病变。
研究设计与样本
- 回顾性队列研究,纳入2009至2018年在一所大学健康服务机构接种流感疫苗的12,870人(24,206次接种),中位年龄20岁(范围16-77),女性占57%。
- 通过电子病历识别ICD-9肩部诊断的就诊记录,比较接种前3个月与后3个月肩痛就诊比例。
- 研究有80%把握度检测接种后肩部问题比例增加0.1%。
- 证据等级为III级,治疗性研究。
主要发现
- 接种前3个月内肩痛就诊比例为1.1%(52/4801),接种后3个月内为1%(40/3977),风险比1.1(95%CI 0.8-1.5;p=0.72)。
- 全部接种中,49%(11,834/24,206)在接种前3个月内、接种后3个月内或两者均有就诊预约,其中1.4%(170次)就诊与肩部问题相关。
- 肩部相关就诊中最常见原因为非创伤性肩痛,占79%(134/170)。
临床怎么用
- 对于疫苗接种后出现的肩痛,不应仅凭时间先后顺序断定为疫苗伤害,需考虑常见肩部疾病如肩袖肌腱病变的可能。
- 应基于全面评估进行鉴别诊断,避免因归因偏误导致误诊和不恰当处理。
局限性
- 研究无法排除罕见的疫苗接种特异性肩部病变。
- 研究基于大学健康服务人群,中位年龄20岁,结果外推至其他年龄人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Shoulder injury from vaccination was approved for automatic compensation from the Vaccine Injury Compensation Program (VICP)-a federal government program started in 1988 to shield the manufacturers of childhood vaccines from liability. The approval was made on the basis of case reports rather than experimental evidence. This, combined with the addition of influenza vaccination to the VICP in 2005 (which broadened coverage to include adults) and other social factors, was associated with a rapid rise in the number of claims of shoulder injury from vaccination over the last decade, which now account for more than half of all claims to the VICP. Given the high prevalence of newly symptomatic sources of shoulder pain such as rotator cuff tendinopathy, combined with the high prevalence of annual influenza vaccinations, there is a substantial risk of overlap leading to the post hoc ergo propter hoc fallacy ("after this, therefore because of this") contributing to misdiagnosis and inappropriate management of patients that perceive injury from vaccination. Records of medical care after a large number of vaccinations have a good chance of detecting serious shoulder pathology, even it is uncommon, which would result in an increased prevalence of visits for shoulder problems and specific types of shoulder pathology. QUESTIONS/PURPOSES: Is there a difference in the proportion of visits for shoulder pain within 3 months before and after vaccination among students and faculty receiving an influenza vaccination in the shoulder? METHODS: We studied people who were vaccinated for influenza between 2009 and 2018 at a university health service. During the study period, a comprehensive billing database identified 24,206 influenza vaccinations administered to 12,870 people (median age 20 years, range 16-77; 57% women). We had 80% power to detect a 0.1% increase in the proportion of shoulder problems after vaccination compared with before vaccination. Visits with coded ICD-9 shoulder diagnoses were identified from the electronic medical record. We compared the proportion of shoulder evaluations within 3 months before and 3 months after vaccination. RESULTS: With the numbers available, the proportion of visits for shoulder problems were not different before (1.1% [52 of 4801]) and after vaccination (1% [40 of 3977], risk ratio 1.1 [95% CI 0.8 to 1.5]; p = 0.72). Among all vaccinations, 49% (11,834 of 24,206) were preceded or followed by an appointment within 3 months before (20% [4801 of 24,206]), after (16% [3977]), or both before and after (13% [3056]) vaccine administration, and 1.4% (170) of these visits were related to a shoulder issue. The most common reason for shoulder-related appointments was atraumatic shoulder pain (79% [134 of 170]). CONCLUSIONS: Shoulder symptoms sufficient to seek care are notably common, even among relatively young adults, and are not more common after vaccination. Although this does not rule out an important rare pathology specific to vaccination, it seems important to consider the potential harms of assuming, based largely on chronology, that persistent shoulder pain after vaccination-something expected to be common based merely on the anticipated frequency of overlap of vaccination and common shoulder problems-represents harm from vaccine. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Gonzalez AI, Kortlever JTP, Moore MG, et al. Influenza Vaccination Is Not Associated with Increased Number of Visits for Shoulder Pain. Clin Orthop Relat Res. 2020. PMID: 32141910. doi:10.1097/CORR.0000000000001215
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。